Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 308 of 308 entries
View as:

A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00601107 Org: User:
Start: 04/30/08 End: 06/30/09 Due: 06/30/10

A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00106509 Org: User:
Start: 03/31/05 End: 02/28/07 Due: 02/28/08

Pompe Pregnancy Sub-Registry

Phase: N/A Priority: Normal
NCT ID: NCT00567073 Org: User:
Start: 06/18/07 End: 01/31/34 Due: 01/31/35

The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)

Phase: N/A Priority: Normal
NCT ID: NCT00444912 Org: User:
Start: 02/28/06 End: 06/30/09 Due: 06/30/10

Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease

Phase: N/A Priority: Normal
NCT ID: NCT01410890 Org: User:
Start: 11/03/14 End: 11/20/20 Due: 11/20/21

Pompe Disease Registry Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00231400 Org: User:
Start: 09/15/04 End: 01/31/34 Due: 01/31/35

Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL

Phase: N/A Priority: Normal
NCT ID: NCT00185445 Org: User:
Start: 06/30/04 End: 10/31/06 Due: 10/31/07

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00103610 Org: User:
Start: 01/31/05 End: 12/31/07 Due: 12/31/08